Furthermore, we demonstrated that MSC‐induced NK resistance in cancer cells was related to an intercellular loop of cGAS‐STING‐IFNβ‐HLA signaling, consistent with the findings of clinical tumor sample analysis. This evidence concerns the gene STING1 and cancer.